Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2017 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports Third Quarter 2017 Financial Results

3% year-over-year growth in recurring revenue and 2% year-over-year growth in global proceduresReduced operating expenses leads to small quarterly operating profitSubstantial progress on strategic...
November 02, 2017 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Report Third Quarter 2017 Financial Results on November 9, 2017

ST. LOUIS, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
September 11, 2017 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Attend Asia Pacific Heart Rhythm Society Conference and Announces Japan Procedure Milestone

ST. LOUIS, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that...
August 28, 2017 09:00 ET | Source: Stereotaxis, Inc.

One Hundred Thousand Procedure Milestone Achieved by Stereotaxis’ Robotic Technology

ST. LOUIS, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS) a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that 100,000...
August 14, 2017 09:00 ET | Source: Stereotaxis, Inc.

Research Finds that Stereotaxis Robotic Technology Provides Significant Advantages in Treatment of Ventricular Tachycardia Compared to Manual Techniques

ST. LOUIS, Aug. 14, 2017 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced the results of an...
August 10, 2017 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports Second Quarter 2017 Financial Results

Stable recurring revenue and 2% year-over-year growth in global proceduresReduced operating expenses and operating lossLaunch of e-Contact™ module in EU and progress in development of strategic...
August 03, 2017 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Report Second Quarter 2017 Financial Results on August 10, 2017

ST. LOUIS, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
July 25, 2017 09:00 ET | Source: Stereotaxis, Inc.

Princess Grace Hospital Publishes Data Demonstrating More Rapid Transmural Lesion Formation Utilizing Stereotaxis Robotic Technology

ST. LOUIS, July 25, 2017 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS) and Princess Grace Hospital in Monaco today announced the publication of a study comparing the speed of lesion formation...
July 11, 2017 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Receives Second Odyssey Vision™ System Orders from Two Leading Heart Hospitals

ST. LOUIS, July 11, 2017 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it has...
June 15, 2017 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Launches the e-Contact™ Module in Europe

ST. LOUIS, June 15, 2017 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the European...